Objective: Using 2019 Centers for Medicare and Medicaid Services data, the authors analyzed performance on behavioral health care quality measures among 168 marketplace insurers offering 185 products and investigated whether performance differed by insurer attributes. Methods: The authors considered four quality measures: antidepressant medication management, follow-up care for children prescribed attention-deficit hyperactivity disorder medication, follow-up care within 7 days after hospitalization for mental illness, and initiation and engagement of alcohol and other drug dependence treatment. Multivariate regression was used to determine whether performance varied by insurers' nonprofit ownership, Blue Cross-Blue Shield affiliation, Medicaid-managed care participation, and preferred provider organization status. Results: Performance levels were highest for management with antidepressant medication and lowest for initiation and engagement of drug dependence treatment. Systematic differences were observed by ownership status and Medicaid-managed care plan status. Conclusions: Increasing the transparency of health plan quality information is important for aiding enrollee decision making and encouraging quality improvement among providers and insurers.
Bibliographical noteFunding Information:
Dr. Drake acknowledges support from the National Center for Advancing Translational Sciences (grant KL2-TR-001856). The views represent the opinions of the authors and not necessarily those of the National Institutes of Health.
© 2021 American Psychiatric Association. All rights reserved.
Copyright 2021 Elsevier B.V., All rights reserved.
PubMed: MeSH publication types
- Journal Article